losartan has been researched along with Dermatitis Medicamentosa in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marquart-Elbaz, C | 1 |
Grosshans, E | 1 |
Lipsker, D | 2 |
Saraceno, R | 1 |
Citarella, L | 1 |
Spallone, G | 1 |
Chimenti, S | 1 |
Haddad, AM | 1 |
Scholer, SG | 1 |
3 other studies available for losartan and Dermatitis Medicamentosa
Article | Year |
---|---|
Sartans, angiotensin II receptor antagonists, can induce psoriasis.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Drug Eruptions; Female; Humans; Los | 2002 |
A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Deri | 2008 |
Possible losartan-induced rash.
Topics: Antihypertensive Agents; Biphenyl Compounds; Drug Eruptions; Female; Humans; Imidazoles; Losartan; M | 1997 |